Assessment of Patients With Suspected Coronary Artery Disease (CAD): What is the Best Initial Imaging Strategy?
IMAGE-CAD
2 other identifiers
observational
173
1 country
1
Brief Summary
Patients who present with chest pain are investigated with tests designed to confirm or exclude the presence of Coronary Artery Disease (CAD), as well as determine risk of poor outcome. It is not known which imaging test would be best when used first for investigating a patient presenting with exertional chest pain. This trial is designed to compare outcomes of the use of coronary CT, stress echocardiography and nuclear perfusion (SPECT) in a pilot study. Patients with no history of coronary disease presenting with chest pain will be randomly assigned to one of the three test modalities as the initial imaging test. The three imaging strategies will be compared regarding the subsequent use of healthcare resources over a year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 13, 2012
CompletedFirst Posted
Study publicly available on registry
August 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedMarch 16, 2017
March 1, 2017
4.5 years
August 13, 2012
March 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
healthcare resource utilization
12 month
Secondary Outcomes (7)
referral rates to coronary angiography following three different initial imaging tests in this patient population.
12 month
coronary lesions which warrant revascularization (including those where it was warranted but not technically possible).
12 month
radiation exposure from the initial and subsequent imaging procedures
12 month
total mortality
12 month
freedom from angina
12 month
- +2 more secondary outcomes
Study Arms (3)
Stress Echocardiography
Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Stress Echocardiography.
SPECT
Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Single Photon Emission Computed Tomography (SPECT)
CCTA
Patients will be randomized to one of three imaging modalities. One imaging modality thay can be randomized to is Cardiac Computed Tomographic Angiography (CCTA)
Eligibility Criteria
Men and women without known CAD who present with symptoms suggestive of CAD and require diagnostic/prognostic workup.
You may qualify if:
- Adult Age ≥ 18 years
- Presenting with symptoms suggestive of CAD requiring diagnostic/prognostic workup
- Suitable for Contrast Stress Echocardiography, SPECT and CCTA
- Able and willing to provide consent
You may not qualify if:
- Patients with documented CAD (previous invasive angiography, previous STEMI, previous PCI or CABG)
- NSTEMI, ACS within 3 months
- Previous diagnostic imaging tests in the past 6 months
- Women who are pregnant as evidenced by positive pregnancy test
- Breast feeding females
- Significant valvular heart disease (i.e. severe aortic stenosis or regurgitation or severe mitral regurgitation)
- Hemodynamic instability (blood pressure \>210/110 ml/Hg or \<90/60 mm/Hg)
- Unavailability for follow-up
- Renal insufficiency, eGFR \< 30 ml/minute unless on dialysis
- Known allergy to x-ray or echo contrast agents
- Weight exceeding specifications of nuclear equipment (\>250 Kg)
- Unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Harald Becherlead
- Alberta Health servicescollaborator
- University of Albertacollaborator
Study Sites (1)
Mazankowski Alberta Heart Institute
Edmonton, Alberta, T6G2B7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harald Becher, MD,PhD,FRCP
University of Alberta, Alberta Health Services
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Heart and Stroke Foundation Chair for Cardiovascular Research
Study Record Dates
First Submitted
August 13, 2012
First Posted
August 20, 2012
Study Start
July 1, 2012
Primary Completion
January 1, 2017
Study Completion
January 1, 2017
Last Updated
March 16, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share